Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$414.2M
41M shares
52-week range
$5.03 – $10.52
93% from low
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NASDAQ
CS
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
www.908devices.comNo one on the platform currently holds MASS.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 230,200 | $1.4M |
No one on the platform has traded MASS yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MASS they have a moat in handheld spectrometry and institutions are starting to notice! The nirlab acquisition was brilliant imho as it shifts away from purely clever handheld device maker with lumpy and spotty sales to integrating with a higher margin sticky recurring AI software platform in addition to providing immediate access to European market ! Reminds me of $BFLY moat. IMHO do your own dd
View on StockTwits ↗$MASS | $9.74 | Vol: 424K | RE·RVOL=1.25·F=27M·52W | MUP_1 | Long
View on StockTwits ↗$MASS finally a great report and share price reaction! Well overdue
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-8-11-908-devices-inc-stock/ $MASS 908 Devices Earnings Transcript
View on StockTwits ↗MASS Q2 2026 Earnings Summary $MASS https://stocktwits.com/news/earnings/ai summaries/mass-q2-2026-earnings-summary/cZoZvcWRJQj
View on StockTwits ↗$MASS Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.32 up 13.51% YoY • Reported revenue of $16.07M up 23.31% YoY • 908 Devices updates its full year revenue guidance range to $68.0 million to $70.0 million, raising the low end of the range and representing 21% to 25% growth compared to 2025 revenue.
View on StockTwits ↗$INTC OPTIONS WATCH Date: July 30, 2026 KEY SUPPORT AND RESISTANCE LEVELS: Key Call Wall: $93.00 Critical Put Wall: $90.00 Gamma Threshold: $91.50 WHALE ACTIVITY: Dark Gamma Range: $91.27 Notable Whale Positions: Whale 1: $81.88 Whale 2: $91.67 Whale 3: $86.30 Whale 4: $92.24 Whale 5: $92.12 VOLATILITY ANALYSIS: Volatility Expectations: Upper Range (1σ): $86.22 Upper Range (2σ): $MASS Lower Range (1σ): $77.54 Lower Range (2σ): $73.20 DAILY LEVELS UPDATE Stay informed about daily updates by following our market analysis.
View on StockTwits ↗@arribaStocktrading @LukasWo yeah the valuation part is always tricky when it comes to deals like this - I held $MASS when its desktop business, which made up about 10% of their sales, got acquired for over $70m, which was higher than their entire market cap at the time. But was it really overvalued? The buyers are no idiots. I agree with you - PSNL is being sold for cheap here on the eve of major breakthroughs. Too bad there isn’t much we can do but to wait it out
View on StockTwits ↗$MASS Had to look up WD-40 business. Sounds good, but it's the unseen TAM that has me in. Miniature mass-spec is 'smell' to drones and robots in the way lidar is the eyes.
View on StockTwits ↗908 Devices Inc. ( $MASS ) SpicyTrade - Daily Stock Analysis https://youtu.be/T95Z0x5CgUc?si=vlK13ld5aYWywPDu
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $69M | +25.4% | $-0.40 | $-0.44–$-0.36 | — | 2 |
| 2027 | $82M | +19.8% | $-0.32 | $-0.51–$-0.07 | — | 3 |
| 2028 | $96M | +17.2% | $-0.24 | $-0.25–$-0.24 | — | 2 |
| 2029 | $102M | +5.8% | $-0.20 | $-0.21–$-0.19 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-11 | $-0.14 | $-0.11 | +22.5% |
| 2026-05-06 | $-0.15 | $-0.22 | -46.7% |
| 2026-03-03 | $-0.06 | $-0.05 | +16.7% |
| 2025-11-10 | $-0.12 | $-0.15 | -30.4% |
| 2025-08-05 | $-0.16 | $-0.18 | -12.5% |
| 2025-05-13 | $-0.27 | $-0.22 | +18.5% |
| 2025-03-04 | $-0.35 | $-0.32 | +8.6% |
| 2024-11-12 | $-0.29 |
| $-0.23 |
| +20.7% |
| $78M |
| — |
| NNOXNano-X Imaging Ltd. | $0.98 | -3.43% | $69M | — |
| NPCENeuroPace, Inc. | $14.51 | -0.34% | $495M | — |
Source: Financial Modeling Prep · peers by sector/industry